Meeting
2019 Gastrointestinal Cancers Symposium
Timing after neoadjuvant therapy predicts mortality in patients undergoing esophagectomy.
Authors
Taylor Maramara
Florida State University College of Medicine, Sarasota, FL
Taylor Maramara , Jamie Huston , Ravi Shridhar , Kenneth L Meredith
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Cancers of the Esophagus and Stomach
Track
Cancers of the Esophagus and Stomach
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 37, 2019 (suppl 4; abstr 157)
DOI
10.1200/JCO.2019.37.4_suppl.157
Abstract #
157
Poster Bd #
M9
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
A prospective translational study investigating the association of gut microbiome (GM) diversity with pathological complete response (pCR) after neoadjuvant treatment in early stage rectal and esophageal cancers.
First Author: Ronan Andrew Mc Laughlin
Poster
2020 Gastrointestinal Cancers Symposium
Variation in treatment patterns and outcomes for resected esophageal cancer at designated thoracic surgery centers.
First Author: Vaibhav Gupta
Poster
2016 ASCO Annual Meeting
Neoadjuvant chemotherapy versus chemoradiation prior to esophagectomy: Impact on rate of complete pathologic response and survival in esophageal cancer patients.
First Author: Albert C. Lockhart
Poster
2012 Gastrointestinal Cancers Symposium
Neutrophil to lymphocyte ratios and pathologic response to neoadjuvant therapy in esophageal cancer.
First Author: Nathan W. Bronson